Harnessing the Membrane Potential to Combat Cancer Progression

Abstract

Rapid fluctuations in the plasma membrane potential (V m ) provide the basis underlying the action potential waveform in electrically excitable cells; however, a growing body of literature shows that the V m is also functionally instructive in nonexcitable cells, including cancer cells. Various ion channels play a key role in setting and fine tuning the V m in cancer and stromal cells within the tumor microenvironment (TME), raising the possibility that the V m could be targeted therapeutically using ion channel-modulating compounds. Emerging evidence points to the V m as a viable therapeutic target, given its functional significance in regulating cell cycle progression, migration, invasion, immune infiltration, and pH regulation. Several compounds are now undergoing clinical trials and there is increasing interest in therapeutic manipulation of the V m via application of pulsed electric fields. The purpose of this article is to update the reader on the significant recent and ongoing progress to elucidate the functional significance of V m regulation in tumors, to highlight key remaining questions and the prospect of future therapeutic targeting. In particular, we focus on key developments in understanding the functional consequences of V m alteration on tumor development via the activation of small GTPase (K-Ras and Rac1) signaling, as well as the impact of V m changes within the heterogeneous TME on immune cell function and cancer progression.

Topics & Concepts